Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) agreed to acquire 51% stake in Hongxi Medical Technology (Tianjin) Co., Ltd. from Li Zhanbing, Tian Bin, Zhang Hengrui and Xiong Rongliang for CNY 0 on January 17, 2024. As of October 31, 2023, Hongxi Medical Technology (Tianjin) Co., Ltd. generated total assets of CNY 0.28 million and net assets of
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.47 CNY | +0.93% | -0.70% | -30.75% |
1st Jan change | Capi. | |
---|---|---|
-30.75% | 201M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.42% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.19% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.